ESC 365 - Expansion of NAC staging system to define poor prognosis: advanced cardiac transthyretin amyloidosis.

HFA Premium Access

Expansion of NAC staging system to define poor prognosis: advanced cardiac transthyretin amyloidosis.

Session: Chronic heart failure - epidemiology, prognosis, outcome 1

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor C. Nitsche (Vienna, AT)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Christian Nitsche

Medical University of Vienna, Vienna (Austria)

2 presentations

2 followers

7 more presentations in this session

Association between vaccination against COVID-19 and clinical outcomes in patients with heart failure: using the Korean National Health Insurance Service database

Speaker: Doctor K. Chun (Goyang, KR)

Cardiovascular and non-cardiovascular prescribing and mortality after takotsubo

Speaker: Mrs A. Rudd (Aberdeen, GB)

Temporal trends in the epidemiology of heart failure during the COVID-19 pandemic years in Germany

Speaker: Doctor T. Stegmann (Leipzig, DE)

Increased cancer incidence in patients with pre-existing heart failure: results from a French nationwide cohort study

Speaker: Professor J. Hulot (Paris, FR)

Right ventricular function in advanced heart failure

Speaker: Doctor K. Steiger (Rochester, US)

Access the full session

Chronic heart failure - epidemiology, prognosis, outcome 1

Speakers: Doctor C. Nitsche, Doctor K. Chun, Mrs A. Rudd, Doctor T. Stegmann, Professor J. Hulot...

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources